Editorial Board of CML Breast Cancer

Advisory Board
 
Christopher Li
Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Umberto Veronesi
European Institute of Oncology, Milan, Italy
 
Clinical Editors

Joy Burchell
King’s College London, London, UK 

Murid Chaudary
BUPA Hospital Bushey, Bushey, UK

David Miles
Mount Vernon Cancer Centre, Rickmansworth, UK 

Lukas Schwentner
University of Ulm, Ulm, Germany

Vincent Vinh-Hung
Geneva University Hospitals, Geneva, Switzerland


READER POLL

Breast Cancer Poll 1
What approach do you currently use for the treatment of patients with HER2-overexpressing metastatic breast cancer whose disease has progressed despite trastuzumab?






Powered by NetPolls

SUBMIT AN ARTICLE